Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BMS Completes Sale of Couvet Site to WuXi STA | Contract Pharma

What are you searching for?

Sign in
Breaking News

BMS Completes Sale of Couvet Site to WuXi STA

Acquisition significantly enhances WuXi STA's drug product capacity in Europe and enhances capabilities by adding capacity to support global customers.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Bristol Myers Squibb has completed the previously announced sale of its manufacturing facility in Couvet, Switzerland, to WuXi STA, a subsidiary of WuXi AppTec.

The divestiture is part of Bristol Myers Squibb’s ongoing progression of its manufacturing network to support its product portfolio. Switzerland remains an important strategic location for the company, and BMS expects to maintain a strong presence in the country.

The Couvet site is located in the canton of Neuchâtel, Switzerland. The site is a state-of-the-art manufacturing facility with commercial-scale production capacity for capsule and tablet dosage forms.

WuXi STA is a pharmaceutical development and manufacturing company serving the life sciences industry. As a CDMO, WuXi STA offers services for integrated chemical, manufacturing and control (CMC) from preclinical to commercial uses. The acquisition significantly enhances WuXi STA’s drug product capacity in Europe and enhances capabilities by adding capacity to support its global customers. The Couvet site is the first facility in Europe for WuXi STA.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics